Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

313 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer.
Heukelom J, Hamming O, Bartelink H, Hoebers F, Giralt J, Herlestam T, Verheij M, van den Brekel M, Vogel W, Slevin N, Deutsch E, Sonke JJ, Lambin P, Rasch C. Heukelom J, et al. Among authors: van den brekel m. BMC Cancer. 2013 Feb 22;13:84. doi: 10.1186/1471-2407-13-84. BMC Cancer. 2013. PMID: 23433435 Free PMC article. Clinical Trial.
Molecular diagnosis of head and neck cancer.
van Houten VM, van den Brekel MW, Denkers F, Colnot DR, Westerga J, van Diest PJ, Snow GB, Brakenhoff RH. van Houten VM, et al. Among authors: van den brekel mw, van diest pj. Recent Results Cancer Res. 2000;157:90-106. doi: 10.1007/978-3-642-57151-0_8. Recent Results Cancer Res. 2000. PMID: 10857164 Review.
Mapping of treatment-induced apoptosis in normal structures: 99mTc-Hynic-rh-annexin V SPECT and CT image fusion.
Kartachova MS, Valdés Olmos RA, Haas RL, Hoebers FJ, van den Brekel MW, van Zandwijk N, Herk Mv, Verheij M. Kartachova MS, et al. Among authors: van den brekel mw, van zandwijk n. Eur J Nucl Med Mol Imaging. 2006 Aug;33(8):893-9. doi: 10.1007/s00259-006-0070-1. Epub 2006 Apr 4. Eur J Nucl Med Mol Imaging. 2006. PMID: 16586080 Clinical Trial.
CD44 expression predicts local recurrence after radiotherapy in larynx cancer.
de Jong MC, Pramana J, van der Wal JE, Lacko M, Peutz-Kootstra CJ, de Jong JM, Takes RP, Kaanders JH, van der Laan BF, Wachters J, Jansen JC, Rasch CR, van Velthuysen ML, Grénman R, Hoebers FJ, Schuuring E, van den Brekel MW, Begg AC. de Jong MC, et al. Among authors: van den brekel mw, van der wal je, van der laan bf, van velthuysen ml. Clin Cancer Res. 2010 Nov 1;16(21):5329-38. doi: 10.1158/1078-0432.CCR-10-0799. Epub 2010 Sep 13. Clin Cancer Res. 2010. PMID: 20837694
Evaluation of tumor shape variability in head-and-neck cancer patients over the course of radiation therapy using implanted gold markers.
Hamming-Vrieze O, van Kranen SR, van Beek S, Heemsbergen W, van Herk M, van den Brekel MW, Sonke JJ, Rasch CR. Hamming-Vrieze O, et al. Among authors: van den brekel mw, van beek s, van herk m, van kranen sr. Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):e201-7. doi: 10.1016/j.ijrobp.2012.03.014. Epub 2012 May 5. Int J Radiat Oncol Biol Phys. 2012. PMID: 22560548
A cost-effectiveness analysis of using TheraBite in a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy.
Retèl VP, van der Molen L, Steuten LM, van den Brekel MW, Hilgers FJ. Retèl VP, et al. Among authors: van den brekel mw, van der molen l. Eur Arch Otorhinolaryngol. 2016 Mar;273(3):709-18. doi: 10.1007/s00405-015-3541-9. Epub 2015 Feb 11. Eur Arch Otorhinolaryngol. 2016. PMID: 25666587 Clinical Trial.
313 results